Correlation Between Unicycive Therapeutics and Vir Biotechnology
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Vir Biotechnology, you can compare the effects of market volatilities on Unicycive Therapeutics and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Vir Biotechnology.
Diversification Opportunities for Unicycive Therapeutics and Vir Biotechnology
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Unicycive and Vir is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Vir Biotechnology go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Vir Biotechnology
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.15 times more return on investment than Vir Biotechnology. However, Unicycive Therapeutics is 1.15 times more volatile than Vir Biotechnology. It trades about 0.23 of its potential returns per unit of risk. Vir Biotechnology is currently generating about 0.02 per unit of risk. If you would invest 38.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 42.00 from holding Unicycive Therapeutics or generate 110.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Vir Biotechnology
Performance |
| Timeline |
| Unicycive Therapeutics |
| Vir Biotechnology |
Unicycive Therapeutics and Vir Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Vir Biotechnology
The main advantage of trading using opposite Unicycive Therapeutics and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Vir Biotechnology vs. CureVac NV | Vir Biotechnology vs. Krystal Biotech | Vir Biotechnology vs. Propanc Biopharma | Vir Biotechnology vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |